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ENGLISH SUMMARY 
Obesity is one of the most obvious manifestations of the global 
epidemic of sedentary lifestyles and excessive energy intake. Obesity 
can increase the risk of developing musculoskeletal pain and negatively 
affects hormones, and fertility potential. Very limited is known about 
the triangle of obesity, pain, and fertility and further investigations are 
crucial to offer better management strategies. This study aimed at 
finding the possible effect of separate and co-existing conditions of 
obesity and pain on male fertility potential while assessing the ability 
of the Lactobacillus rhamnosus PB01 probiotic supplementation as a 
novel strategy to reverse the negative effects of the mentioned 
complications. This PhD project comprised of both human and animal 
studies. The human study was based on chronic pain patients and pain-
free healthy matched controls, select-recruited to create two equal 
subgroups of normal weight (lean) and overweight. Sperm 
concentration, motility groups, kinematic parameters, DNA 
fragmentation index and morphology were assessed and compared by 
computer aided sperm analysis (CASA). Pressure pain thresholds 
(PPTs) were measured by a handheld pressure algometer in pre-defined 
points. The animal study was performed on normal weight, and diet-
induced obesity (DIO) models of C57BL/6NTac male mice, randomly 
divided into two sub-groups continuing the same diet but receiving 
either a single daily dose (1x109 CFU) of L. rhamnosus (test group) or 
physiological saline (control group) for 4 weeks. Sensitivity to 
mechanical stimulation was assessed by an electronic Von Frey device 
every second week. Serum total antioxidant capacity (TAC), 
reproductive hormones levels, and lipid profiles were assessed by 
enzyme linked immunosorbent assay (ELISA). Results of the human 
phase demonstrated that PPT values were generally lower in the 
overweight chronic pain patients group compared to the respective 
control groups; however, the deference remained insignificant. Lean 
men with chronic musculoskeletal pain demonstrated a significantly 
lower percentage of progressively motile sperm and insignificantly 
lower concentration, lower normal morphology, and higher DNA 
fragmentation levels. The overweight chronic pain group had a 
tendency towards a lower concentration and percentage of 
progressively motile sperm and significantly lower kinematic 
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parameters (VCL: curvilinear velocity, STR: straightness, and WOB: 
wobble) compared to the overweight control groups. In the animal 
phase, the DIO group had a reduced serum TAC, while probiotic 
supplementation was found to increase TAC in both DIO and normal 
control groups. The DIO group demonstrated a clear reduction in 
several kinematic parameters (VCL, STR, VSL: straight-line velocity, 
VAP: average path velocity and LIN: linearity) including the 
percentage of progressive motile sperm, which were reversed 
proportionally in the DIO probiotics supplemented group. Collectively, 
the human study demonstrated a negative effect of chronic pain and 
obesity on the sperm characteristics as a marker of male fertility 
potential in lean humans. Due to the overlapping effects of obesity and 
chronic pain on the sperm characteristics, the statistical analysis of the 
results in this study cannot conclude a solid opinion on the possible 
effect of chronic pain on sperm quality in co-existing conditions of pain 
and overweight. Further research in overweight and lean chronic pain 
patients is required to confirm this hypothesis.  
This PhD project aimed to find the possible effect of separate and co-
existing conditions of obesity and pain on male fertility potential, taking 
into consideration Lactobacillus rhamnosus PB01 probiotic 
supplements as a new strategy to counter the negative effects of the 
mentioned complications. 
Chronic musculoskeletal pain demonstrated slightly altered hormonal 
balance in normal weight and proved to have a negative effect on sperm 
concentration and kinematic parameters (VCL, VSL, VAP, BCF), 
expressed as a lower percentage of non-progressive, progressive and 
hyper activated spermatozoa. The mouse models demonstrated that oral 
supplementation of Lactobacillus rhamnosus PB01 may well be a 
potentially innovative approach to the regulation of weight and 
nociception, while also positively affecting male fertility, especially in 
cases of obesity. This study supports the hypothesis of "the potentially 
positive effect of probiotics on both weight and pain as well as sperm 
quality" which can naturally be followed up as a possible strategy for 
treatment of sub-fertile obese men.
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DANSK RESUME 
Fedme er en af de mest åbenlyse manifestationer af den globale tendens 
til stillesiddende livsstil og overdrevent energiindtag. Fedme kan øge 
risikoen for at udvikle smerter i bevægeapparatet og negativt påvirke 
hormoner og fertilitetspotentiale. Der er en meget begrænset viden om 
sammenhængen mellem fedme, smerte og fertilitet. Yderligere 
forskning er derfor afgørende for at kunne tilbyde bedre strategier. 
Dette studium er et forsøg på at finde den mulige effekt af separate og 
sammenhængende tilstande af fedme og smerte på det mandlige 
fertilitetspotentiale. Her afprøves Lactobacillus rhamnosus PB01 
probiotisk supplement som en ny strategi til at forhindre den negative 
effekt af de nævnte komplikationer. 
 Nærværende studium er sammensat af en nærværende stadium er 
sammensat af/baseret op humane studier samt dyremodeller. Den 
humane fase var baseret på patienter med kroniske smerter og smertefri 
og sunde matchede kontrolpersoner udvalgt med henblik på at oprette 
to lige store undergrupper med henholdsvis normal vægt og overvægt. 
Koncentrationen af sædceller, motilitet, kinematiske parametre, DNA 
fragmentation index og morfologi blev undersøgt og sammenlignet ved 
hjælp af med computerstøttet sædanalyse (CASA). Smertegrænser ved 
mekanisk tryk (PPT) blev målt ved hjælp af et håndholdt tryk-algometer 
i præ-definerede punkter.  
Den animalske fase blev udført på modeller af C57BL/6NTac hanlige 
mus med henholdsvis "normal vægt" eller "kost-induceret fedme 
(DIO)". Disse to grupper af mus var hver tilfældigt opdelt i to lige store 
undergrupper, som fik henholdsvis en enkelt daglig dosis (1 x 109 CFU) 
af L. rhamnosus (testgruppen) eller fysiologisk kogsaltopløsning 
(kontrolgruppen) og den samme kost gennem 4 uger. Sensitiviteten 
over for mekanisk stimulation blev vurderet af en elektronisk Von Frey 
hver anden uge. Serum total antioxidant kapacitet (TAC), niveauet af 
reproduktionshormoner og lipid profiler blev vurderet vha. ELISA 
(enzyme linked immunosorbent assay).  
Resultaterne af den menneskelige fase viste, at PPT værdier var generelt 
lavere i gruppen af overvægtige patienter med kroniske smerte 
sammenlignet med de respektive kontrolgrupper, omend ikke statistisk 
signifikant. Slanke mænd med kronisk musculoskeletal smerte havde 
en signifikant lavere procentdel progressivt motile sædceller og 
signifikant lavere koncentration og normal morfologi og et højere 
10 
DNA-fragmentations niveau.  Gruppen af overvægtige patienter med 
kroniske smerter havde en betydeligt lavere procentdel af ikke-
progressive motile og statiske sædceller (P<0,05) og en ubetydeligt 
lavere tendens i kinematiske parametre (progressiv motilitet, VCL, 
VSL, VAP og BCF) i forhold til de overvægtige kontrolgrupper. 
   
I den animalske fase havde DIO gruppen en nedsat serum TAC, mens 
probiotisk tilskud blev fundet for at forhøje TAC i både DIO og normal 
kontrolgrupper. DIO-gruppen viste en klar reduktion i flere kinematiske 
parametre (VCL, VSL, VAP, STR og LIN) herunder procentdelen af 
progressivt motile sædceller, der var forholdsmæssigt omvendt i den 
probiotika supplerede DIO-gruppe.  
 
Alt i alt viste den humane fase en negativ effekt af kronisk smerte og 
fedme på mandlig fertilitetspotentiale hos slanke mænd. P. gr. af den 
overlappende effekt af fedme og kronisk smerte på sperm 
karakteristika, kan en statistisk analyse af resultaterne i dette studium 
ikke føre til en klar konklusion vedr. den mulige effekt af kronisk 
smerte på sædkvalitet. Yderligere forskning i overvægtige og slanke 
patienter med kroniske smerter er nødvendig, før man kan bekræfte 
denne hypotese. 
 
Dette PhD-projekt havde til formål at finde den eventuelle effekt af 
separate og co-eksisterende forhold af fedme og smerte på mandlig 
fertilitetspotentiale og samtidig vurdere Lactobacillus rhamnosus PB01 
probiotisk tilskud som en ny strategi til at modvirke de negative 
virkninger af de omtalte komplikationer. Kroniske smerter i 
bevægeapparatet i normalvægtige patienter ændrede hormonbalancen 
og viste sig at have en negativ effekt på koncentrationen af sædceller 
og de kinematiske parametre (VCL, VSL, VAP, BCF) som et udtryk 
for en lavere procentdel af ikke-progressive, progressive og 
hyperaktiverede spermatozoer. Musemodellerne demonstrerede, at 
orale tilskud af Lactobacillus rhamnosus PB01 meget vel kan være en 
potentielt innovativ tilgang til regulering af vægt og nociception, 
samtidig med, at det også positivt kan påvirke den mandlige fertilitet, 
især i tilfælde af fedme. Denne undersøgelse understøtter hypotesen om 
"den potentielt positive effekt af probiotika på såvel vægt og 
smertebehandling som sædkvalitet". Dette kan naturligt følges op som 
en mulig strategi til behandling af subfertile overvægtige mænd. 
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INTRODUCTION 
1.1. OBESITY 
The body mass index (BMI) or “Quetelet index” is defined as the body 
mass divided by the square of the body height, and universally 
expressed in units of kg/m2, resulting from mass in kilograms and 
height in meters. Table 1 provides a classification for overweight and 
obesity based on BMI [1].  
The prevalence of obesity is advancing. A systematic analysis has 
reported the number of overweight and obese individuals to have 
increased from 921 million in 1980 to 2.1 billion in 2013 worldwide 
[2]. The Danish society has also demonstrated an increasing trend in the 
prevalence of obesity [3]. The “Danish National Health Profile” by the 
“Danish Health Authority” in 2010 (den nationale sundhedsprofil 2010) 
has reported that 54.3% of the Danish population suffer from moderate 
to severe obesity with 14.3% falling in the severe obesity group [4]. 
 
Table 1. Classification of overweight and obesity based by Body Mass Index (BMI) (“WHO | 
Obesity: preventing and managing the global epidemic,” 2015). 
 Obesity Class BMI (Kg/m2) 
Underweight  <18.5 
Normal  18.5 – 24.9 
Overweight  25.0 – 29.9 
Obesity I 30.0 – 34.9 
 II 35.0 – 39.9 
Extreme Obesity III ≥40 
 
An overwhelming number of medical conditions including insulin 
resistance, diabetes mellitus, glucose intolerance, dyslipidemia, 
hypertension, arthritis, hyperuricemia, gall bladder disease, sleep apnea 
and certain types of cancer have been associated to obesity [5].  Other 
diseases such as coronary heart failure, stroke, cardiac arrhythmia and 
artery disease have also been independently associated to obesity [5]. 
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Obesity does more than produce alarming numbers; it also leads to 
damaged or negatively affected health and it is associated with several 
health conditions such as increasing the risk of heart attack, stroke, 
hypertension, diabetes, gallstones, cancer, osteoarthritis, obstructive 
sleep apnea, fatty liver, and depression [6–8]. BMI has also been noted 
as a decisive factor in infertility and consequently assisted reproductive 
technology (ART) treatment strategies [9].  
 
1.2. PAIN AND NOCICEPTION 
Nociception or pain is a large field of medical research and 
neuroscience and the distinction between the two is important to 
consider when performing clinical and preclinical research.  
The International Association for the Study of pain has defined pain as 
“an unpleasant sensory and emotional experience associated with actual 
or potential tissue damage, or described in terms of such damage” 
(International Association for the Study of Pain, 1994), whereas 
nociception is defined as “the neural processes of encoding and 
processing noxious stimuli” [10]. 
A recent study has described pain as an emotional result of several 
impulses, which originate from the nociceptors in somatic and visceral 
tissues [11].  These impulses travel in peripheral nerves, with a first 
synapse in the dorsal horn and a second synapse in the thalamus. They 
end up in the cerebral cortex and other supraspinal structures which 
results in a pain experience and activation of reflex and reflective 
behaviors, collectively aimed at eliminating further pain [11,12]. It is 
next expected, that the nociceptor-driven pain will be stopped 
successfully and further healed to recover and regain a pain-free state 
[11].  
Chronic pain is classified as pain that exceeds 3 months duration [12] 
and has been categorized as localized, regional or widespread with a 
majority of cases  associated with musculoskeletal pain [13]. It has been 
previously illustrated that chronic and acute pain have different 
underlying Mechanisms [14]. In chronic pain conditions, the 
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association between nociception and pain experience is incorrect or 
absent. Therefore, the expected recovery does not occur [11].  
The release of neuropeptides from the nerve endings can sensitize 
nociceptors. This may lead to hyperalgesia and central sensitization of 
dorsal horn neurons, which are expressed as prolonged neuronal 
discharges.  
As mentioned above, acute pain is the result of a strong unpleasant 
stimulus, to express area of tissue damage. There is a clear alteration 
from acute pain with a distinct change in the damage area, to chronic 
pain, where there might be permanent tissue damage. However, chronic 
pain may remain due to central pain, even though the tissue has been 
healed [15].  
Pain can also be caused by the direct stimulation of nociceptors due to 
release of inflammatory mediators such as histamine, bradykinin, 
chemokines and cytokines[16,17]. The development of inflammatory 
pain is linked to the activation of intracellular signaling pathways and 
increased levels of proinflammatory cytokines. Inhibiting the action of 
the proinflammatory cytokines has also been suggested a possible 
strategy in the treatment of inflammatory pain [18,19]. 
Acute inflammation is a natural physiological response to infection or 
tissue injury. One of the primary characteristics of inflammatory states 
is allodynia  in which a normally innocuous stimuli can produce pain 
[16]. Thus, chronic inflammation is maladaptive and can also cause 
considerable pain. In response to chronic inflammatory pain, the 
chemical mediators accountable for tissue inflammation affect the 
nociceptive nerve endings to lower the neuronal excitation threshold 
[20].  As a result of released inflammatory substances associated with 
primary tissue damage, nerve cells, pain receptors and the surroundings 
of the nerve signal will change [11,21]. This phenomenon 
(neuroplasticity) refers to alterations in synapses and neural pathways 
due to changes in environment, behavior, and neural process as well as 
changes resulting from physical injury like obesity [21,22] 
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1.3. INFERTILITY 
Infertility in general, refers to a couple having failed to conceive a baby 
after 12 months of regular unprotected sexual intercourse. About 15% 
of couples worldwide are affected by infertility with male factor 
contributing to 50% of cases overall [23].  
Fertility is a significant component of reproductive health in general 
and infertility expands beyond the psychological entity and reaches to 
a social concept [24]. It can have serious implication on physiological, 
physical, economic, and social wellbeing for both spouses [24].  
Today, infertility can be well-thought-out as a public health issue [25]. 
Reproductive health and success is affected by many lifestyle factors 
including obesity, inappropriate diet, not exercising or exercising 
excessively, psychological stress, delayed child bearing, smoking, 
alcohol and/or caffeine consumption, and exposure to environmental 
pollutants and chemicals [26,27]. 
Reduced sperm quality is one of the main causes of male infertility. The 
sperm quality is dependent on several parameters including the volume, 
concentration, and total count of spermatozoa, motility, vitality, and 
morphology [28].  
Causes of male infertility can include the defective spermatogenesis 
due to pituitary disorders, germ cell aplasia, varicocele, testicular 
cancer and environmental factors or to flawed sperm transfer as a result 
of congenital abnormalities or immunological and neurogenic factors 
[29]. In 15% of infertile men, the infertility is caused by genetic factors 
which may be hereditary or a consequence of environmental factors, 
leading to DNA damage in precursors of the spermatozoa [30]  
In 2012, Jørgensen et al. demonstrated that only 23% of Danish men, 
have an acceptable sperm quality, which is the lowest sperm quality 
amongst the European countries [31]. 
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1.4. CO-EXISTING CONDITIONS 
1.4.1. OBESITY AND PAIN  
One of the associate conditions to obesity is pain, and musculoskeletal 
pain. Obesity has been, for example, implicated in the development or 
progression of low back pain [32]. The mechanism of action by which 
obesity leads to lumbar back pain is not completely understood [33]. 
Obesity has been suggested to be affecting the discs directly through 
mechanical stress on the intervertebral discs or by the indirect effects 
on blood flow to the lumbar spine, subsequently leading to low back 
pain [33,34]. Further research to elucidate the exact mechanism is 
needed. However, theoretically, obesity over time seems to contribute 
to low back pain and that brings an idea that weight loss may help 
prevent the onset, severity, and pain intensity of low back pain in obese 
people. The link between obesity and knee osteoarthritis (OA) has also 
been demonstrated [35], but potential factors underlying the association 
of obesity with OA have not entirely been elucidated. However, 
previous studies have demonstrated that obesity leads to an excess load 
on the joint, increased cartilage turnover, increased collagen type 2 
degradation products, and increased risk of degenerative meniscal 
lesions. Although all of these factors have been theorized to lead to knee 
OA, no causal relationships have been demonstrated [36,37]. 
Results from some studies suggested that treatment of obesity lead to 
reduced weight and subsequently pain, while other studies observed 
pain and weight as primary outcomes; however, variæøability in 
measurements makes comparisons and conclusions rather difficult [38]. 
While available evidence strongly suggests that comorbid obesity is 
common in chronic pain conditions [39,40] there is still much to learn 
about the nature of the co-occurrence between overweight/obesity and 
pain.  
Identifying and clarifying the relationship between pain and obesity 
without being influenced by the many other confounding factors can 
further complicate the process of designing, running and interpreting 
the results of studies on overweight/obesity. Therefore, researchers 
need to use “state of the art” measurement and rigorous scientific 
methodology when focusing on expanding knowledge of the 
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relationship between pain and obesity. In addition, developing 
explanatory models that address co-occurrence of overweight/obesity 
and pain seem required to examine any subsequent effects on health-
related outcomes. Finally,  evaluating and testing treatments that most 
effectively target comorbidities and meet the needs of the ever-growing 
population of individuals struggling with both overweight and pain 
would be an ultimate goal [38]. 
1.4.2. OBESITY AND MALE INFERTILITY 
Infertility (also referred to as subfertility in the literature) has been 
defined as “the inability to conceive after one year of regular 
unprotected sexual intercourse” [41]. 
Obesity in adult men has in recent years been associated with low 
semen quality [42–47], but not consistently [48–50]. Adult male obesity 
has also been linked to sub-fecundity, as measured by a prolonged 
waiting time to pregnancy [51–53]. Overweight men have lower 
concentrations of testosterone, sex hormone binding globulin (SHBG), 
and inhibin B, and higher concentrations of estradiol, but unaffected or 
only slightly lower concentrations of luteinizing hormone (LH) and 
follicle-stimulating hormone (FSH) [44,45,48,50,54–56]. 
Overweight men also frequently show T deficiencies possibly 
contributing to a decreased semen quality [57], seen as decreased total 
sperm count (TSC) [45], increased frequency of oligozoospermia [42], 
and a significantly negative relationship between BMI and total number 
of normal, motile sperm [46]. 
Many studies are demonstrated that the decrease in semen quality and 
male reproductive potential over the past half century may be lead to 
the increasing rate of obesity. According to Carlsen et al., there has been 
a substantial decrease in semen quality, and due to the effect of low 
semen quality on male fertility, plausibly an overall decline in male 
reproductive potential can occur [58]. 
Observations by some studies demonstrated that male sperm counts 
continue to decrease by as much as 1.5% per year in the United States 
[59]. These results are similar to those found in other Western countries 
and countries in which obesity is more prevalent, but do not exist in 
regions in which obesity is less common [60]. Furthermore, another 
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study also reported that patients with male-factor infertility show a 
significant growth in the incidence of obesity, and couples with obese 
male partners experience sub-fecundity more often, a correlation that 
seems necessary to be addressed [61]. 
Since this decline has occurred relatively in parallel with increasing 
rates of obesity, it is highly important to focus on the possibility of 
obesity as an etiology of male infertility and reduced fecundity. The 
‘obesity pandemic’ seen in many countries is a serious threat to public 
health, and a reduced capacity to reproduce is a potential but less well- 
known health hazard attributed to obesity [59,62–64]. 
 
1.4.3. RESEARCH ON CO-EXISTENCE OF OBESITY, PAIN, 
AND INFERTILITY 
As mentioned in the above sections, possible links between obesity, 
certain pain conditions and infertility have been shown to some extent. 
However, to the best of our knowledge, a possible association amongst 
obesity, pain and infertility in males or females has not been 
investigated.  
Research on chronic pain and fertility has been mainly focused on 
painful conditions related to chronic pelvic pain e.g. endometriosis in 
women or prostatitis in men [65–67]. However, other chronic pain 
conditions and how those can alter the fertility have been less studied 
and it is still not clear whether pain alone, or under obesity condition 
can lead to infertility. In addition, the influence of different pain 
therapeutics on fertility or the effects of fertility treatments on pain have 
not been systematically investigated. 
When it comes to the scenario where all these three conditions co-exist, 
it makes it even more complicated as the obesity condition and its 
related treatments might influence both pain and fertility and vice versa.  
Since these three conditions of obesity, chronic pain, and infertility are 
common health-related problems and affect the quality of life of the 
affected individuals and pose a burden to the society and health care 
system, it would be highly valuable to find the association if any and to 
identify whether it would be possible to break the negative link between 
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these conditions to pave a new road for better management or treatment 
of obesity, chronic pain and fertility. 
The Danish Fertility Society has administered a guideline in June 2013, 
suggesting BMI as a deciding factor for assisted reproductive 
technology (ART) treatment, which also emphasizes on the importance 
of this type of studies in the clinical prospective.  
 
1.4.4. CURRENT OBESITY AND WEIGHT–LOSS 
TREATMENTS 
Obesity and weight-loss treatments range from simple strategies such 
as increased physical activity and making diet and lifestyle changes to 
pharmacotherapy using medicines, which block fat absorption or 
increase fat-metabolism. Weight-loss (bariatric) surgery is another 
strategy for people incapable of making the mentioned lifestyle and 
behavioral changes [68]. 
Anti-obesity drug discovery has generally seen many false starts, 
failures in clinical development, and withdrawals due to adverse effects, 
which were not known or fully anticipated during the studies. Many 
preclinical studies have demonstrated some potential of the drugs 
aiming pathways in metabolic tissue (e.g. adipocytes, skeletal muscle, 
and liver) [69], but very few have reached clinical development (e.g. 
orlistat, liraglutide and metformin ) [70]. 
Many studies have linked the intestinal microbiome with overall health 
including obesity; therefore, the metabolism regulating role of the gut 
microbiota has become a focus of study for the management of 
obesity and its associated comorbidities [71–74]. 
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1.4.5.  PROBIOTICS: 
1.4.5.1 The weight-regulatory effect of probiotics 
 
The microbial community of the gut is recognized as one of the most 
important factors connected to obesity and metabolic disorders [75–77]. 
Previous findings strongly suggest that gut microbiota contribute to the 
complications related to high-fat diet feeding. There are many studies 
reporting the anti-obesity effect of Lactobacillus, through mechanisms 
such as and regulation of leptin [78], regulation of lipid and glucose 
metabolism [76,79], increase of numbers of small adipocytes and 
decreasing of adipocyte size in white adipose tissue [80,81], and 
production of conjugated linoleic acid [82,83]. 
Moreover, probiotic supplementation can mimic key aspects of 
microbial symbiosis, which may enhance reproductive fitness in 
mammalian hosts [84]. 
 
It would thus be useful to develop specific strategies using probiotics to 
modify gut microbiota to favor a specific strain (i.e., lactobacillus) and 
to prevent the deleterious effects of high-fat or obesity-induced 
complications.  
Studies have reported increased natural killer cell (NK) activity and 
inflammatory type responses with the administration of some probiotic 
strains [85]. The oral application of L.casei strain Shirota has also been 
reported to have increased the inflammatory immune response levels 
associated cytokine IL-2 [86]. 
 
1.4.5.2 The anti-inflammatory effect of probiotics 
Different internal and external challenges can interfere with the normal 
balance of the healthy gut microflora [74] while the composition and 
function of a balanced normal microflora may also be directed by 
inflammation to become immunogenic and aberrant, leading to the 
continuation of the inflammation and subsequently gut barrier 
dysfunction. 
 However, the negative effect of this change may be reversed by oral 
supplementation of specific strains of the indigenous healthy gut 
microflora which have been reported to normalize the balance of the 
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intestinal microbiome, possibly eliminating the cycle leading to 
inflammation [74,87]. 
The reported strong anti-inflammatory capability demonstrated by the 
most common probiotics [88], may be mediated by neutralizing the 
inflammatory process through enhancing the degradation of enteral 
antigens, decreasing the secretion of inflammatory mediators, 
promoting the balance of the indigenous flora, and excluding the 
pathogens [87,89]. 
In 2008, Kekkonen et al. reported that probiotics have an anti-
inflammatory potential seen as a decrease in serum C-reactive 
protein (CRP) levels and as a reduction in bacteria-induced production 
of pro-inflammatory cytokines in peripheral blood mononuclear cell 
(PBMC) in healthy adults [90].Several studies have demonstrated the 
capability of probiotics to reduce nociception [91], hypersensitivity and 
visceral pain in cases of colonic inflammation [92], irritable bowel 
syndrome [93–96] and diet-induced obesity [91] and non-inflammatory 
IBS-like models [97]. 
However, no previous study to our knowledge, has focused on the effect 
of probiotics for the management of somatic pain. 
 
1.4.5.3 Probiotics and fertility 
Some previous publications have pointed out the possible beneficial 
effect of probiotics on the vaginal flora [98] and female urogenital 
diseases [99,100] with more recent studies focusing on the biological 
control of vaginosis [101], female fertility and pregnancy [102,103]. 
The use of probiotics on male fertility has also been assessed in some 
recent studies.  A completely randomized experimental design study on 
male murine models compromised by high-fat diet demonstrated 
significantly improved sperm indexes, reduced testicular tissue injury 
and increased serum testosterone levels [104]. 
Another study on the bacterial communities in semen from men of 
infertile couples has suggested that Lactobacillus might not only be a 
potential probiotic for semen quality maintenance, but also might be 
helpful in countering the negative influence of Prevotella and 
Pseudomonas [105]. 
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1.4.6. OBESITY AND WEIGHT–LOSS IN THE TREATMENT 
OF INFERTILITY (ART) 
Obesity research, as it relates to reproduction and pain, requires a 
transdisciplinary approach because these are complex systems affected 
by environmental, biological and genetic influences to name a few 
[106]. Therefore, tackling the problem of reproduction in obese men 
will require cooperative efforts among experts in each dimension of 
these research fields. 
There is a significant degree of doubt when choosing a strategy for 
treating obese patients suffering from infertility, where predictive 
decision making models may be helpful [107]. 
Ultimately, this type of research may help to form models of shared 
decision making in which physicians and patients mutually decide how 
to proceed with strategies for the treatment of patients suffering from 
pain and/or infertility. Such models which consider the potential risks 
and benefits of an individual (at a given age, certain weight range, pain 
level, etc.), could potentially offer a strategy including weight loss 
before or during fertility treatment. Current approaches to treat obesity-
induced male infertility have been demonstrated in Figure 1. 
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Figure 1 Approaches to treat obesity-induced male infertility (Cabler et al., 2010b) 
 
 
1.4.7. PROBIOTICS IN CO-EXISTENCE OF OBESITY, PAIN, 
AND INFERTILITY 
Despite the separate studies on the effect of probiotics on weight, pain 
and fertility management and improvement, no study to date has 
assessed the effect of probiotics in a triangle condition where all these 
problems co-exist. 
  
Treatment 
Modalities 
Lifestyle Changes 
Diet 
Exercise 
Behavior therapy 
Pharmacological 
interventions 
Appetite 
suppressants 
Weight loss drugs 
Surgical options 
ART 
Scrotal lipectomy 
Bariatric surgery 
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1.5. AIMS AND HYPOTHESIS: 
The first aim of this PhD study was to perform an investigational study 
to examine the possible link between obesity, pain, and fertility in the 
male gender in humans. The second aim was to assess the potential 
effect of probiotic Lactobacillus rhamnosus PB01 (DSM 14870) on 
weight management, nociceptive and mechanical sensitivity regulation, 
and sperm quality as a biomarker of male fertility in a diet-induced 
obesity murine model. The overall PhD study design, including the 
human and animal phases has been illustrated in figure 2. 
Animal models have been demonstrated to provide insights into the 
pathophysiology of the phenomenon [108] while allowing for 
exploratory interventional studies. Accordingly, this PhD study was 
designed to apply a translational approach. 
Paper I: Effects of chronic musculoskeletal pain on fertility 
potential in lean and overweight male patients. 
Assessed hypothesis: “Obesity and chronic pain induce a negative 
effect on sperm quality (motility, morphology, DNA fragmentation 
index, etc.) as a biomarker of male fertility potential.” 
Paper II: Potential Nociceptive Regulatory Effect of Probiotic 
Lactobacillus rhamnosus PB01 (DSM 14870) on Mechanical 
Sensitivity in Diet-Induced Obesity Model  
Assessed hypothesis: “Probiotic lactobacillus rhamnosus 
PB01induces weight-loss and reduces nociception in diet induced 
obesity mice models”. 
Paper III: Lactobacillus rhamnosus PB01 (DSM 14870) 
supplementation affects markers of sperm kinematic parameters in a 
diet-induced obesity mouse model. 
Assessed hypothesis: Probiotic lactobacillus rhamnosus PB01induces 
weight-loss and reverses the negative effect of obesity on sperm 
motility as a biomarker of male fertility potential. 
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Figure 2. Illustration of the overall PhD study including the human and animal phases. (ND: Normal diet, 
FD: high fat diet, PR: probiotic. 
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MATERIALS & METHODS 
1.6. PAPER I (HUMAN STUDY): EFFECTS OF CHRONIC 
MUSCULOSKELETAL PAIN ON FERTILITY POTENTIAL IN 
LEAN AND OVERWEIGHT MALE PATIENTS  
In this study, a questionnaire survey was designed to recruit two groups 
of age matched overweight and lean male patients suffering from 
chronic pain. Reproductive hormone levels and sperm quality including 
motility, morphology and sperm DNA fragmentation index were 
assessed as biomarkers of male fertility potential for all patients. This 
assisted in finding a possible association between obesity; chronic pain 
and fertility in the study population.  
This study was done at the Orthopedics department, Aalborg University 
Hospital, and Fertility Clinic in Dronninglund, Denmark from June 
2014 to December 2015, following approval by the Scientific Ethics 
Committee of the Northern Jutland Region, Denmark (approval 
reference no. N-20140025). 
For this study, 20 chronic pain patients and 20 pain-free healthy 
matched controls were recruited. The participants in each of these 
groups were select-recruited to create two equal subgroups of normal 
weight and overweight subjects.   
The following inclusion and exclusion criteria were used (as indicated 
in the ethical approval protocol):  
 
1.6.1. INCLUSION CRITERIA: 
✓ Patients (men) within the age range of 18-46 years, attending 
the orthopedic outpatient clinic located at the Aalborg 
University Hospital, suffering from low back pain or knee pain. 
✓ Pain more than 3 months. 
✓ Patients can be on a daily use of Paracetamol 1 gram x 4, 
NSAID x -3-4 or combined. Patients will be included regardless 
of their BMI but will be put in their respective BMI subgroup 
after the required measurements have been taken. 
✓ Regarding low back pain the LBPRS > 9, Knee pain the KOOS 
≤75 (0-100, i.e. 100 = no problems) 
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✓ Healthy men in the age 18-46 years (matched with enrolled 
patients)  
 
1.6.2. EXCLUSION CRITERIA: 
Cases of:  
✓ Malignancy 
✓ Ongoing infection  
✓ Drug addiction including cannabis, opioids or other psycho 
drugs  
✓ Previous musculoskeletal, neurologic or mental illnesses 
✓ Lack of ability to cooperate 
✓ Patients with a pain rate of below 3 will be excluded 
✓ Medication 
✓ Patients taking Morphine drugs. 
 
1.6.3. DESIGN AND METHODS: 
The study was consisted of age matched groups of men 18-46 years old. 
These groups were defined as the following: 
Group I: Overweight patients with chronic pain (OP)  
Group II: Overweight patients without chronic pain (OC)  
Group III: Lean patient with chronic pain (LP)  
Group IV: Lean patient without chronic pain (LC)  
 
1.6.4. DESCRIPTION OF TESTS  
For each participant, height, and weight were measured and body mass 
index (BMI) was calculated. Demographics information, such as 
gender, age, ethnicity, level of education, history of chronic knee pain, 
pain medication and other information which might be possible 
confounders including caffeine intake, alcohol intake, smoking status 
(never, past, current, unknown), reproductive history, reproductive 
surgery and abstinence time were collected. 
  
Blood samples were collected and analyzed at the Clinical 
Biochemistry Department at Aalborg University Hospital by trained 
professionals based on the hospital routine protocols. A volume of 9 ml 
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of blood was collected from each patient and assessed for lipid profiles 
(triglyceride, total cholesterol, low/very low density lipoprotein 
(LDL/VLDL)), high density lipoprotein (HDL), and hormone levels 
including: testosterone, luteinizing hormone (LH), follicle-stimulating 
hormone (FSH). These procedures performed for healthy olunteers (as 
controls) like patient. After the tests, the remaining blood was 
discarded. 
 
Afterwards, the participants were tested for their pain in terms of 
intensity (magnitude) and quality. Intensity was rated on a visual 
analogue scale (VAS 0-10) for ongoing pain, and pressure pain 
threshold was measured by application of a handheld pressure 
algometer (Somedic, Sweden) to identify muscle sensitivity. A 
validated Danish version of short form McGill Pain Questionnaire (SF-
MPQ-2) was given to evaluate the quality of pain based on pain related 
word descriptors. In addition, distribution of pain was mapped by 
drawing on body charts included in this questionnaire. More 
information on these tests is given below. 
 
1.6.5. ASSESSMENT OF PAIN CHARACTERISTICS: 
1.6.5.1 Ongoing pain intensity (on VAS0-10):  
The participants were asked to rate their pain intensity at rest condition 
at the time of experimental visit on a visual analogue scale by placing a 
horizontal mark on a 10 cm VAS where 0 means no pain and 10 is the 
most imaginable pain.  
 
1.6.5.2 Pain quality (on SF-MPQ-2): 
The SF-MPQ-2 includes four subscales (constant pain (6 items), 
intermittent pain (6 items), neuropathic pain (6 items) and affective 
descriptors (4 items)) for a total of 22 items asking about pain 
symptoms over the past week. The response to each item was scored on 
an 11-point numeric rating scale (0 = none; 10 = worst possible). A total 
score was calculated by summing the scores for each item. The SF-
MPQ-2 has a high internal consistency and construct validity with the 
34 
Multidimensional Pain Inventory (MPI) severity scale in people with 
different pain conditions. 
 
1.6.5.3 Pain drawings (on body charts) 
To map the area of pain distribution, body charts were given and 
patients were asked to draw on the charts wherever in the body they 
sense pain. 
 
1.6.5.4 Assessment of evoked pain by mechanical 
stimulation  
Pressure algometry has been used in clinical and experimental settings 
for testing of tissue sensitivity to mechanical pressure (Bovim, 1992; 
Arendt-Nielsen, 1997).  
Pressure pain thresholds (PPTs) were measured by a handheld pressure 
algometer (Somedic, Sweden) in predefined points around the knee (in 
total 5 points) and one reference point on upper arm of non-dominant 
hand. Subjects were instructed that the PPT is ‘the point at which the 
pressure sensation just becomes painful’. Each measure was repeated 
three times with a stimulus interval of 1 min. Averages of the three 
repetitions were used for analysis. The pressure was delivered at a 
constant rate (30 kPa/s) by the investigator while the algometer tip (1 
cm2 probe area) applied perpendicularly at the stimulation site of the 
target tissue. A window display on the pressure algometer aids in the 
application of pressure at a constant rate.  
This test was performed for all participants in both healthy control and 
patient groups.  
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1.6.6.  BIOLOGICAL SAMPLE (SPERM) COLLECTION:  
Semen samples were collected by masturbation and allowed to liquefy 
for 30-45 minutes at room temperature. Following liquefaction, the 
volume was measured using a graduated pipette; samples were then 
divided into three parts in small sampling tubes and used for the 
following assessments: 
 
1.6.6.1 Concentration, Motility, and kinematic parameters: 
A “Leja chamber slide” (20 μm deep) (Leja Products B.V., Nieuw 
Vennep, Netherlands) was filled with five micro-liters of the liquefied 
sperm suspension and assessed at a total magnification of 100X using a 
Nikon E50i microscope equipped with a phase contrast condenser and 
a Basler sca780 (Basler, Germany) camera. The motility and 
concentration module of the Sperm Class Analyzer (SCA®, Ver. 5.4, 
Barcelona, Spain) computer aided sperm analysis (CASA) system was 
used to analyze the concentration and detailed kinematic parameters of 
the spermatozoa. 
 
The detailed motion parameters provided by the SCA were used to 
categorize the sperm into different velocity and progression groups 
according to the current WHO reference values [109]. 
The reference and cut-off values used by the SCA® for the 
categorization of human and animal spermatozoa have been illustrated 
in the papers included in the appendix section.  
 
1.6.6.2 Morphology 
Air-dried sperm smears were stained using “Spermblue” (Microptic 
S/L, Barcelona, Spain) per the manufacturer’s instructions assessed 
using the morphology module of the SCA system at 1000X 
magnification.   
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1.6.6.3 DNA fragmentation (Halosperm kit) 
The DNA fragmentation of the samples was performed using the 
Halosperm kit (Halotech, Madrid, Spain) according to the 
manufacturer’s instructions. 
In general, unfixed sperm cells are immersed in an agarose micro gel 
on a slide, incubated in an acid unwinding solution that transforms 
DNA breaks into single-stranded DNA, followed by immersion in a 
lysing solution to remove protamines. After staining, the spermatozoa 
without fragmented DNA show stained nucleoids with big halos of 
spreading of DNA loops, whereas those with fragmented DNA appear 
with a small or no halo. The halo sizes and fragmentation index were 
assessed using the “SCA® DNA fragmentation” module. 
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1.7. PAPER II AND III (INTERVENTIONAL ANIMAL STUDIES) 
Paper I, demonstrated an association between obesity, chronic pain, and 
fertility in the defined sub-populations of the human patients (Obese 
and lean patients with or without chronic musculoskeletal pain).   
In parallel, animal studies were designed and performed to examine if 
probiotic based diet programs can be used as a novel weight 
management strategy to reduce nociception and improve the sperm 
quality in diet induced obesity (DIO) mice models.  
Paper II and III were based on animal models to reduce the confounding 
factors due to the feasibility and possibility of using a restricted and 
controlled diet while also providing the possibility of some required 
invasive assessments not possible in human studies. Furthermore, the 
animal studies were required as a proof of concept, efficacy, and safety, 
in order to be able to acquire the required approvals to initiate human 
trials in collaboration with the probiotic producing company (Bifodan 
A/S, Hundested, Denmark) 
 
1.8. PAPER II: “POTENTIAL NOCICEPTIVE REGULATORY 
EFFECT OF PROBIOTIC LACTOBACILLUS RHAMNOSUS 
PB01 (DSM 14870) ON MECHANICAL SENSITIVITY IN DIET-
INDUCED OBESITY MODEL” [91]. 
1.9. PAPER III: “LACTOBACILLUS RHAMNOSUS PB01 (DSM 
14870) SUPPLEMENTATION AFFECTS MARKERS OF 
SPERM KINEMATIC PARAMETERS IN A DIET-INDUCED 
OBESITY MODEL” 
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1.9.1. ANIMALS IN PAPER II, III: 
A total of twenty-four, 6 weeks-old male C57BL/6NTac mice were 
acquired from Taconic (Ejby, Denmark). The mice were housed at the 
Aalborg University Hospital animal facility (Aalborg, Denmark) and 
maintained in accordance with Danish Animal Protection Act 
(12/09/2015). 
The mice (one mice per cage), were allowed to acclimatize in an 
environmentally controlled room (22°C and 60% relative humidity) 
under a 12-hour light/12-hour dark schedule for two weeks.  
All mice were weighed every two weeks throughout the experiment. 
Furthermore, the mice were allowed a 2-week period of adaptation 
before the commencement of the experiment receiving food and water 
ad libitum. All the animal experiments in this study were performed 
under approval by the Danish Animal Experiments Inspectorate (AEI), 
Denmark (2014-15-0201-00026) and according to the guidelines of 
“the ethical committee for research on laboratory animals” of Aalborg 
University. 
 
1.9.2. EXPERIMENTAL DESIGN: 
Phase I (Week 1-4): Following adaptation, the mice were randomly 
assigned to two groups, receiving either a standard or a high fat diet 
(60%) (D12492, Research Diets Inc., USA).  The mice on standard diet 
were used as the normal weight (NW) model while the group on high-
fat diet resulted in the diet-induced obesity (DIO) model.  
 
Phase II (Week 5-8): Each of the DIO and NW groups were then 
divided into two subgroups randomly, and maintained on their previous 
diet. One DIO subgroup and one NW subgroup were randomly selected 
as the test group, receiving a single daily dose of Lactobacillus 
Rhamnosus diluted in normal saline while the other two subgroups 
received only normal saline with no probiotic supplement (control 
group) by intra-gastric administration (gavage), for four weeks. 
The above procedure resulted in the following four groups: ND 
(Normal Diet), NDPR (Normal Diet + Probiotic supplement), FD (Fat 
diet) and FDPR (Fat diet + Probiotic supplement). 
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1.9.3. PRESSURE PAIN SENSITIVITY: 
Sensitivity to mechanical stimulation by electronic von Frey was 
performed every second week (3 times on each mice) by placing the 
mice in an acrylic box (15 × 15 cm) with a metal mesh floor (5 × 5mm 
square openings) preventing extra movement while providing enough 
room to show reaction. 
This test evaluated how soon paw withdrawal due to mechanical 
pressure occurred. The more sensitive the paw, the faster the 
withdrawal, which would be reflected on lower pressure amount. 
Before preforming the “pressure pain threshold” test the mice were 
weighed using a digital scale. 
A steadily increasing pressure was applied to the plantar surface of the 
mouse’s hind-paw by a filament (0.1–10 𝜇L pipette tip) loaded on to 
the sensor of the Von Frey device, until withdrawal occurred. The 
amount of pressure (g) at the time of hind-paw retraction was recorded 
by the Von Frey device. Averages of three consecutive readings (with 
3-minute intervals) from the same hind paw were recorded for further 
statistical analysis. 
  
1.9.4.  BIOLOGICAL SAMPLE (SPERM AND BLOOD) 
COLLECTION, AND ELISA ASSAYS: 
Blood samples from the facial vein of conscious mice were collected at 
baseline and end of weeks 4 and 8. Centrifugation (500 g for 10 min at 
4C) was used to obtain blood serum which was stored at −20C until 
being used to assess blood lipid profiles (HDL, LDL/VLDL, total 
cholesterol, and cholesterol) using a commercially available ELISA 
assay kit (ab65390, ABCAM, UK) based on the manufacturer’s 
directions.  
The serum testosterone, FSH and LH levels were assessed using the 
total antioxidant capacity kit (ab65329, Abcam, United Kingdom), 
testosterone ELISA kit (ab108666, Abcam, United Kingdom), FSH 
ELISA kit (MBS703380, MyBioSource, U.S.A) and LH ELISA kit 
(MBS041300, MyBioSource, U.S.A), respectively (according to the 
manufacturers protocols). 
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1.9.5. PREPARATION OF SPERM SUSPENSIONS: 
Sperm collection and preparation of suspension were carried out using 
a modified procedure. Briefly, the caudal portion of the epididymis was 
placed in 30-mm petri dishes containing 2ml DMEM (Dulbecco's 
Modified Eagles Medium), cut open longitudinally and washed (by 
pipetting with the DMEM medium) to flush out all spermatozoa. The 
epididymis was then removed and the sperm supernatant fluid could 
incubate for 20 to 30 min at 37°C before being used for the analysis of 
sperm parameters. 
 
1.9.6. SPERM ANALYSIS: 
Sperm samples were assessed using the Sperm Class Analyzer (SCA®, 
version 5.4.0.0, Microptic S.L., Barcelona) for sperm motility and 
kinematic parameters similar to the procedure mentioned above. 
RESULTS 
1.10. PAPER I: EFFECTS OF CHRONIC MUSCULOSKELETAL 
PAIN ON FERTILITY POTENTIAL IN LEAN AND 
OVERWEIGHT MALE PATIENTS 
1.10.1. PAIN INTENSITY AND QUALITY: 
The minimum and maximum pain intensity levels within last 3 months 
on the VAS. scale was respectively reported to be 5.15 ± 2.21 cm and 
7.78 ± 1.97 cm for the overweigh patients, and 4.7 ± 1.97 cm and 8.01 
± 1.77 cm for the lean chronic pain patients.  
Throbbing, shooting, boring, sharp, hot, taut, exhausting, grueling, 
blinding and nauseating were the maximum (30%) reported descriptors 
of pain via chronic pain patients. 
LP and OP showed a decreasing tendency compared to LC and OC; 
however, no statistically significant difference was detected in any 
other measured spots among the sub-groups (Paper I, Table2). The 
anatomic sites for pressure pain threshold evaluations over the muscles 
are demonstrated in Paper I (figure1).   
 
1.10.2. SEMEN ANALYSIS: 
1.10.2.1  Concentration, motility, and sperm kinematic 
parameters 
The percentage of progressively motile sperm was significantly lower 
(P≤0.05) in LP group compared to LC group; however, LP group 
demonstrated a higher percentage of non-progressively motile sperm 
compared to the LC group. A same trend in OP group was seen 
compared to the matched healthy controls, however it remained 
insignificant. (Paper I, Table 3).  
Moreover, the sperm motion kinematics was significantly affected by 
chronic pain. For more information refer to Paper I (Table 4).  
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1.10.2.2 Morphology and DNA fragmentation 
LC and OC groups demonstrated lower, but not significant trend, in 
DNA fragmentation compared to LP and OP groups. Entirely, there was 
no difference in morphology and DNA fragmentation in lean and 
overweight chronic pain patients compared with the matched healthy 
controls (Paper I, Table 3). 
 
1.10.2.3 Blood serum lipid profile and reproductive 
hormones: 
There was no significance difference in plasma testosterone levels in 
lean and overweight chronic pain patients compared with the matched 
healthy controls and the levels remained within the reference ranges for 
the hormone (10.3 - 27.4 nmol/L) (“Testosteron (R-nr. 515) - Statens 
Serum Institut,” 2015). FSH and LH levels were found to be  lower in 
LP and OP groups compared to math healthy groups, however 
insignificant. The OP and LP group also demonstrated higher 
cholesterol levels compared to OC; however, that was also insignificant 
(Paper I, Table 5). 
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1.11. PAPER II AND III: 
PAPER II: EFFECT OF LACTOBACILLUS RHAMNOSUS 
PB01 ON DIFFERENT ASPECTS OF OBESITY, PAIN, AND 
FERTILITY POTENTIAL IN ANIMAL TRAIL: 
PAPER III: LACTOBACILLUS RHAMNOSUS PB01 
SUPPLEMENTATION EFFECTS ON BODY WEIGHT AND 
TESTICULAR WEIGHT: 
 In week 4, groups on a high fat diet, had gained significantly higher 
weight in comparison to the group on normal diet (P<0.01) and 
maintained a rising trend after week 4. The probiotic supplemented 
groups upheld a steady weight without any significant change until the 
end of the study at week 8 (Paper II, Figure 1). 
FD group demonstrated the significant rising trend in gaining weight in 
week 8 (P<0.002).  
However, The NDPR and FDPR groups maintained a stable weight 
after week 4, following the start of probiotic supplementation (Paper II, 
Figure 1). 
In regards to testicular weigh, normal diet groups with or without L. 
rhamnosus did not demonstrate any significant difference while 
probiotic supplemented DIO group showed significantly higher 
testicular weight compared to DIO group without probiotics (0.127 ± 
0.01 gr and 0.117 ± 0.01 gr, respectively). 
 
1.11.1. L. RHAMNOSUS PB01 SUPPLEMENTATION 
EFFECTS ON PRESSURE PAIN THRESHOLD: 
After 4 weeks of the probiotic supplementation, both normal diet and 
diet–induced obese mice demonstrated remarkable changes in the pain 
pressure threshold (PPT) values (Paper II Figure 1). 
 
PPT ranges were between 15 and 17.7 g in the baseline. During the first 
2 weeks of the study, a slight increase was observed in the PPT values 
with no significant difference between the normal or fat diet groups; 
however, this difference became clearly significant at week 4 (P<0.01) 
(Paper II Figure1). 
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In week 8, all groups showed a significant (P<0.01) difference in the 
PPT results. 
Pain pressure thresholds in the NDPR, FDPR, ND and FD groups, were 
(22.17, 16, 12 and 7.83) grams respectively (Paper II Figure1). As a 
remarkable point, NDPR demonstrated the highest PPT results.  
 
1.11.2. L. RHAMNOSUS PB01 SUPPLEMENTATION 
EFFECTS ON LIPID PROFILES, REPRODUCTIVE 
HORMONES AND TOTAL ANTIOXIDANT CAPACITY: 
Paper II, Table 1 presents the blood serum lipid profiles (serum total 
cholesterol, LDL-cholesterol, HDL-cholesterol), reproductive hormone 
levels (LH, FSH and testosterone) and total antioxidant capacity of the 
mice at following 8 weeks on the respective diet with or without 
probiotic supplementation. 
 
1.11.3. L. RHAMNOSUS PB01 SUPPLEMENTATION 
EFFECTS ON SPERM MOTILITY (PROGRESSION): 
No significant difference was seen in the percentage of sperm 
categorized by progressive motility, between the groups on normal diet 
regardless of probiotic supplementation.  
However, a significantly lower percentage of immotile sperm and a 
significantly higher percentage of non-progressively and progressively 
motile sperm were observed in the normal diet group (ND) compared 
to the fat diet group (FD) (Paper III Figure 2). 
A significantly higher percentage of non-progressively (P≤0.05) and 
progressively motile (P≤0.01) sperm and a significantly lower 
percentage of immotile (P≤0.01) sperm were also seen in the probiotic 
supplemented fat-diet group (FDPR) compared to the fat diet group 
(FD) (Paper III Figure 2). 
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1.11.4. L. RHAMNOSUS PB01 SUPPLEMENTATION 
EFFECTS ON SPERM KINEMATIC PARAMETERS: 
The FD group demonstrated lower values in all the kinematic 
parameters when compared to the ND group (Paper III Figure 3).  
The probiotic supplemented high fat diet and normal diet groups 
(NDPR and FDPR) demonstrated higher values of VCL, VAP, VSL, 
BCF and ALH compared to the groups without probiotic 
supplementation in week 8 (ND and FD); however, the deference 
remained insignificant. A significant difference in VSL (P<0.01), VAP 
(P<0.05) and VCL (P<0.05) was seen between the FD and FDPR group 
(Paper III Figure3). A comparison of the kinematic parameters of sperm 
in the DIO and NW groups, with and without probiotic supplementation 
after 4 weeks has been illustrated in (Paper III Figure 3). 
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DISCUSSION 
 
1.12. HUMAN STUDY: 
The main purpose of the human study (Paper I) was to investigate if 
patients suffering from obesity, musculoskeletal chronic pain, or a 
combination of the two, demonstrate different pain sensitivity to 
mechanical pressure (pressure pain threshold), reproductive hormone 
levels and sperm quality in comparison with age-matched healthy 
controls. It was also investigated, whether chronic pain in lean or 
overweight subjects is related to the possible change in sperm quality. 
The novelty of this study resides in investigating the influence of 
chronic pain, as a factor by itself, or in combination with obesity, on 
male fertility potential.  
To the best of the author’s knowledge, this is the first investigation on 
biomarkers of male fertility including sperm motility and detailed 
kinematic parameters, sperm morphology, DNA fragmentation and 
reproductive hormone levels in lean and overweight chronic pain 
patients compared to age-matched healthy controls.  
 
1.12.1. ASSOCIATION BETWEEN OBESITY, CHRONIC 
PAIN, AND SPERM QUALITY: 
Study of lean and overweight male chronic pain patients compared to 
age-matched healthy controls demonstrated that chronic pain patients 
have a generally lower sperm quality in terms of sperm motility, 
compared with healthy matched controls. This difference in the sperm 
quality was observed as significantly lower percentage of progressively 
motile sperm in the lean chronic pain group compared to the lean 
control group while the overweight chronic pain group demonstrated 
significantly lower VCL, STR and WOB compared to the overweight 
control group.  
Our findings in musculoskeletal pain confirm the results from a meta-
analysis by Fu et al., in 2014 [110] on male fertility indicating that 
chronic pelvic pain syndrome (CPPS) significantly reduces sperm 
concentration and sperm kinematic parameters.  
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Both lean and overweight chronic pain patients also demonstrated 
decreased testosterone levels compared with the healthy matched 
controls; however, insignificant. A possible explanation for this change 
could be that chronic pain can induce a stress response through 
persistent stimulation of the nociceptors and this recurrent stressor on 
the hypothalamic–pituitary–adrenal (HPA= axis and Gonadotropin-
releasing hormone (GRH) axis, may lead to decreased testosterone 
plasma levels [110–113].Testosterone is intricately involved in 
endogenous opioid activity [114,115]; therefore, adequate levels of 
testosterone could produce pain control in males while decreased 
plasma testosterone levels could result in raised muscle sensitivity 
reflected on lower (PPT) values, allowing for testosterone to play a role 
in pain modulation [112,116,117].   
The lower testosterone levels in LP and OP groups could explain the 
tendency to decreased PPT values, which is in line with the previously 
conducted studies demonstrating decreased PPT values in chronic-pain 
patients [117–121].   
Testosterone also has an important role in spermatogenesis; therefore, 
an alteration in the testosterone secretion could result in the dysfunction 
of the production and maturation process of the spermatozoa, 
consequently affecting the sperm concentration and kinematic 
parameters. Accordingly, our study demonstrated significant 
differences in the sperm kinematic parameters, but no difference in 
morphology and DNA fragmentation between LP and LC groups. No 
significant correlation was demonstrated between chronic pain, 
hormonal profiles and the PPT values. The LH and testosterone 
hormone levels were not significantly different in the overweight test 
and control groups but the tendency similar to what was seen in the 
“lean groups” can still be found. LH levels was higher in obese 
musculoskeletal chronic pain patients and FSH and testosterone levels 
was lower in obese musculoskeletal chronic pain patients. 
The previously proven negative effect of overweightness on sperm 
quality, which could overlap and cover the possible effect of 
musculoskeletal chronic pain, could be another explanation for why the 
differences of the parameters in the overweight groups are not 
significant. 
 
The statistical analysis of the results in this study cannot conclude if 
musculoskeletal chronic pain has an influence on sperm quality in obese 
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patients. More research on a larger number of obese chronic pain 
patients (e.g. 45 patients in each group with power of above 80%) with 
further focus on differentiating the effect of obesity from chronic pain 
in overweight patients is required before a definite conclusion can be 
made. 
1.13.  INTERVENTIONAL ANIMAL STUDIES: 
The interventional animal studies were designed to investigate the novel 
idea of using the previously proven “weight-gain control” [71] and 
“anti-inflammatory” [122] effect of probiotics (Lactobacillus 
rhamnosus pb01) supplementation to reverse the adverse effects of 
chronic pain on sperm quality in lean mice (Paper II).  
Considering somewhat inconclusive results on the effect of chronic 
pain in overweight patients, the interventional animal studies could also 
provide an insight and allow for further evaluation on the relation 
among obesity, chronic pain, and sperm quality in a fully controlled 
setting. It was also hypothesized that the mentioned properties of 
probiotics may also result in lower pain sensitivity (Paper II, III). 
These studies were based on animal models (mice) of obesity due to the 
feasibility and possibility of using a restricted and controlled diet and 
related ethical issues. Animal models also provided the possibility of 
some required invasive assessments, which were not possible in 
humans. 
 
1.13.1. EFFECT OF PROBIOTICS ON BODY WEIGHT, LIPID 
PROFILE AND HORMONE LEVELS: 
In the present study, we observed that feeding C57BL/6NTac mice a 
high fat diet for 4weeks produced significant increases in body weight 
(diet-induce obesity models). Oral Administration of Lactobacillus 
rhamnosus supplementation resulted in a significantly reduced body 
weight. Several previous studies have also reported the anti-obesity 
effects of some bacterial strains such as Lactobacillus spp. [75–77]. 
Our results demonstrated that the total cholesterol (TC) and low density 
lipoprotein (LDL) levels in serum were decreased and high density 
lipoprotein (HDL) level was increased in the FDPR group compared to 
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FD. The hypercholesterolemic effect of probiotics in both mice and 
human has also been reported ins several previous studies [123–130]. 
In contrast, a few studies have reported that probiotics have no 
influence on lipid profile changes [70,131–133]. These controversial 
results could be due to the differences in the used strains, and dissimilar 
delivery methods where the probiotic carrier (matrix) could have 
influenced the cholesterol-decreasing effect of probiotics [134]. 
Our results showed that the testosterone, LH and FSH levels in serum 
were increased in the FDPR group compared to FD group.  Lower level 
of testosterone in the DIO groups in this study, could be a result of a 
possible degeneration of Leydig cells due to the detrimental effects of 
cholesterol-rich diets on the secretory capacity of Leydig and Sertoli 
cells. 
Serum estrogen levels would raise as the result of the conversion of 
androgens to estradiol [135,136], which can be associated with the 
lower levels of LH and FSH in the DIO group.  
Following the increased estradiol levels in obese models, the production 
and secretion of FSH and LH would be reduced resulting in reduced 
intra-testicular and circulating testosterone function and production 
[136,137]. The direct toxic effect of excessive estradiol on 
spermatogenesis has also been previously suggested [136,137].  
1.13.2. EFFECT OF PROBIOTICS ON PRESSURE PAIN 
THRESHOLD: 
Our results revealed that the pressure pain threshold rates were 
increased in the FDPR group compare to FD, which can show lower 
sensitivity in this group.  
Several  studies have confirmed that probiotics have powerful anti-
inflammatory effects [86,88,90]. This anti-inflammatory effect could 
also be an explanation for the reduced pain sensitivity in the probiotic 
supplemented test groups observed in this study. Nevertheless, other 
unidentified mechanisms may have also been involved. 
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1.13.3. EFFECT OF PROBIOTICS ON SPERM MOTILITY 
AND SPERM KINEMATIC PARAMETERS: 
The most important feature of the spermatozoon is sperm motility. It is 
known as a main indicator of sperm function [138]. 
Our results revealed significantly higher percentage of progressively 
motile sperm and significantly lower percentage of immotile (static) 
sperm in FDPR groups compared to (FD). This finding confirms the 
adverse effects of obesity and beneficial effects on sperm motility  
[46,139–143], while also supporting the results of previous studies 
assessing the effect of probiotics in rodents [104,144]. 
The diet induced obesity mice showed lower values in all kinematic 
parameters, which are also observed as the reduction in the level of 
progressive motility, possibly implying that spermatozoa are unable to 
migrate along the female reproductive tract efficiently to reach the site 
of fertilization in-vivo [143]. 
The increased motion path parameters including linearity (Lin), 
straightness (STR) and beat cross frequency (BCF) and significantly 
(P<0.05) higher velocity parameters (VSL, VCL and VAP) in the 
probiotic supplemented DIO group compared to the respective control 
groups without probiotic supplementation suggest a general capability 
of probiotics in reversing the deleterious effects of DIO on sperm 
swimming speed. 
The mechanisms behind this decline of motility in the obese mice may 
be related to the decrease in serum testosterone, because of increased 
estradiol levels alongside with the general adverse effects of increased 
body weight; while the weight reduction and hormone regulating effect 
of the probiotics could be the considered as the mechanism behind the 
better quality of the sperm in the probiotic supplemented groups. 
However, an exact mechanism is yet to be identified. 
The detailed kinematic parameters of sperm assessed by CASA have 
been less focused in the literature. The motion parameters including 
linearity (Lin), straightness (STR) and beat cross frequency (BCF) were 
increased in both DIO and NW groups after 4 weeks of probiotic 
supplementation while ALH was marginally-significantly (P=0.057) 
higher in the FDPR compared to the FD group.  
The sperm in the “rapid velocity” category demonstrated significantly 
higher average VSL, VCL, VAP and ALH values in the probiotic 
supplemented DIO groups. This increase in velocity parameters can be 
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interpreted as increased capability of sperm to reach the oocyte in the 
female reproductive tract and further emphasizes the positive effect of 
probiotic supplementation on the kinematic parameters of the sperm.  
High-fat diet can provoke oxidative stress leading to sperm damage 
while probiotic supplementation may improve sperm quality to some 
extent by reducing the level of oxidative damage [144]. Other 
Lactobacillus rhamnosus strains (L. rhamnosus GG) have demonstrated 
similar capabilities including significant increase in seminiferous 
tubule cross-sectional profiles, increased Leydig cell numbers per testis 
and spermatogenesis in mice [145]. 
This is the first study reporting the capability of probiotics in reversing 
the adverse effects of DIO on sperm kinematic parameters. The 
mechanism of action behind this finding has not been yet investigated, 
but could be associated with the increasing level of testosterone during 
spermatogenesis and maturation, reducing the level of oxidative 
damage and inducing weight loss, which would also possibly reduce 
scrotal fat regulating of the testes’ temperature. 
In this relation, recent studies focusing on diet and exercise 
interventions in an obese mouse model [146] have also reported that the 
sperm function is correlated with the metabolic health of an individual. 
Therefore, the ability of probiotic supplementation in improving 
metabolic health through mechanisms such as the lowering of 
cholesterol to normal levels could be associated with improvements in 
molecular compositions such as reductions of oxidative stress and 
reduced DNA damage resulting in a better sperm motility [146].   
Further investigation is still required to determine the exact mechanism 
of action for the protective effect of probiotics on the sperm kinematic 
parameters 
  
52 
CONCLUSION: 
Paper I: The excessive impact of obesity itself on the sperm parameters 
renders it rather difficult to distinguish the distinct effect of 
musculoskeletal chronic pain on sperm quality in overweight human 
patients. However, musculoskeletal chronic pain in lean human patients 
altered the balance of reproductive hormone levels and demonstrated a 
significant negative effect on progressively motile sperm percentage.  
Paper II and III: When assessing similar conditions in animal models, 
irrespectively of the underlying mechanism, Lactobacillus rhamnosus 
PB01 demonstrated a potential as an innovative approach for the 
management of weight and nociception. In addition, this probiotic 
could positively affect the male fertility potential, especially in obese 
groups. 
Translation of the weight and nociception regulating effect of the 
probiotics to humans may potentially suggest a novel beneficial 
strategy in conditions where male infertility, obesity and pain co-exist. 
Overall, due to the previously demonstrated excessive adverse effects 
of obesity on sperm characteristics, the results of the human phase of 
this study should be interpreted cautiously. A study with a larger sample 
size would be required to provide a conclusive conclusion on the 
different effects of obesity and chronic pain on sperm characteristics 
 
 
1.14. PERSPECTIVES AND FUTURE STUDIES: 
A study with a large number of samples in both male and female models 
from different strains and species is suggested to provide solid and 
reliable results and account for the possible overlapping of the effect of 
obesity and pain, variability in sperm kinematics and/or hormonal 
influence.  
Another study on DIO models, focusing on the effect of the probiotic 
supplementation in relation to pain induced by injecting an algogenic 
substance or creating injury neuropathic models could provide more 
concrete confirmation of the nociceptive-regulatory effect of probiotics. 
In addition, a diverse range of outcome measures and biomarkers, 
would provide better insight in underlying mechanisms. 
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Furthermore, metabolomics proteomics and gene expressions analysis 
should be conducted to identify the underlying mechanisms behind the 
weight and nociception regulation and its consequent effect on male 
fertility potential.  
Human clinical trials, assessing the effect of probiotics on fertility 
potential, and inflammatory -pain are required. Translation of the 
results from this animal study to humans could lead to a novel beneficial 
strategy to manage co-existing cases of male infertility, obesity, and 
pain. 
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